Zydus Lifesciences informs about board meeting

03 Feb 2023 Evaluate
Zydus Lifesciences has informed that the Board of Directors at their meeting held today February 3, 2023. Based on the recommendations of Audit Committee, approved the Unaudited Financial Results for the quarter / nine months ended on December 31, 2022. It enclosed the Unaudited Financial Results (standalone and consolidated) for the quarter / nine months ended on December 31, 2022, reviewed by the Audit Committee and taken on record by the Board of Directors pursuant to regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations); the Limited Review Reports of Deloitte Haskins & Sells LLP, Chartered Accountants and the Statutory Auditors of the Company, certifying the limited review of the Unaudited Financial Results (standalone and consolidated) of the Company for the quarter/ nine months ended on December 31, 2022 pursuant to regulation 33 of the Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

924.35 -7.10 (-0.76%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×